LINCOMYCIN OUBARI 500 mg is a lincosamide antibiotic, it is administrated by oral route.

Each LINCOMYCIN OUBARI 500 mg capsule contains: Lincomycin as HCl 500 mg.

LINCOMYCIN OUBARI is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate.

LINCOMYCIN OUBARI may be administered concomitantly with other antimicrobial agents when indicated.

Pregnancy& breast-feeding

Pregnancy: there are no adequate and well-controlled studies in pregnant women. LINCOMYCIN OUBARI should be used during pregnancy only if clearly needed. (Pregnancy category: C).

Breast-feeding: a decision should be made whether to discontinue nursing, or to discontinue the drug, taking into account the importance of the drug to the mother.

Infections due to susceptible organisms: 500 mg three times a day. (every 8 hours).

More severe infections: 500 mg 4 times a day. (every 6 hours).

For optimal absorption, it is recommended that nothing be given by mouth for a period of 1 to 2 hours before or after oral administration of Lincomycin.